Download MendeleyA Highly Selective and Versatile Probe Platform for Visualization of Monoacylglycerol Lipase.
Hentsch, A., Guberman, M., Radetzki, S., Kaushik, S., Huizenga, M., Paul, J., Schippers, M., Benz, J., Kuhn, B., Heer, D., Topp, A., Esteves Gloria, L., Walter, A., Hochstrasser, R., Wittwer, M.B., von Kries, J.P., Collin, L., Blaising, J., van der Stelt, M., Lipstein, N., Grether, U., Nazare, M.(2025) Angew Chem Int Ed Engl 64: e202413405-e202413405
- PubMed: 39916545
- DOI: https://doi.org/10.1002/anie.202413405
- Primary Citation of Related Structures:
9G4M - PubMed Abstract:
Monoacylglycerol lipase (MAGL) is a key enzyme for signal termination in the endocannabinoid system (ECS). MAGL inhibition results in indirect activation of the cannabinoid receptors, which offers unique advantages for the treatment of, e.g., multiple sclerosis, epilepsy, and other neurological disorders. Molecular imaging techniques are valuable tools to overcome the current poor understanding of MAGL's distribution and role in patho- and physiological processes within ECS signaling. Herein, we report the design, synthesis, and validation of highly selective versatile fluorescent and click-chemistry probes for MAGL. Structure-based design combined with a reverse-design approach allowed the development of a structural unit that selectively and effectively recognizes MAGL while offering a versatile platform to attach different fluorophores and further reporter units. In this way, labeled probes with sub-nanomolar potency carrying diverse fluorescent dyes were obtained. Probe affinity and selectivity remained invariant to changes in the fluorophore subunit, showing the remarkable robustness of this platform in delivering tailor-made probes. Highly consistent inhibition across species supports pharmacological model translatability. Extensive profiling and validation in various cellular systems shows the ability of these highly potent and selective probes to elucidate the complex role of MAGL in ECS cellular signaling, inflammatory processes, and disease progression.
- Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.
Organizational Affiliation:
